A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

Also called NCT02998840

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 132 participants (enrolled count) (from the registry)
Sponsor
AOBiome LLC (from the registry)
Registry
  • NCT NCT02998840
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02998840. Randomized; double masking; primary purpose treatment. Start 2016-11 (actual); primary completion 2017-04-25 (actual). Results posted on 2022-08-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
Condition
Prehypertension
Condition
Hypertension, Stage I
Intervention (Biological)
B244
Intervention (Biological)
Vehicle
Lead sponsor
AOBiome LLC (class: industry)
Collaborator
Veristat, Inc. (class: other)

Record details

Record id
cardio:ct-nct02998840
Content hash
a90544208db956e5ac39f11c8cb955b263554ff5c2ead093dbe7479d64ac115c